Literature DB >> 9176086

Topical glyceryl trinitrate relaxes the sphincter of Oddi.

W Luman1, A Pryde, R C Heading, K R Palmer.   

Abstract

BACKGROUND/AIM: Nitric oxide (NO) may be involved in non-adrenergic non-cholinergic (NANC) inhibitory innervation of the sphincter of Oddi (SO). The effects of topical application of glyceryl trinitrate (GTN), a NO donor, upon SO motility were examined.
METHODS: Nineteen patients undergoing routine SO manometry for investigation of abdominal pain were studied. After routine recording of SO motility, they were randomised into three groups to receive 10 ml of normal saline, 5 mg GTN (0.5 mg/ml) or 10 mg (1 mg/ml) GTN. Drug solutions were infused topically onto papilla via the manometry catheter and recordings were continued for a further 5 minutes.
RESULTS: There was no significant change in SO motor variables following application of normal saline. GTN reduced SO tonic and phasic contractions. In four patients, there was complete abolition of all phasic contraction.
CONCLUSIONS: Local application of GTN inhibits SO motility. This may have application for diagnostic and therapeutic biliary endoscopy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176086      PMCID: PMC1027132          DOI: 10.1136/gut.40.4.541

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Sphincter of Oddi manometry in healthy volunteers.

Authors:  M Guelrud; S Mendoza; G Rossiter; M I Villegas
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation.

Authors:  M Staritz; T Poralla; H H Dormeyer; K H Meyer zum Büschenfelde
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

4.  The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation.

Authors:  J S Gillespie; X R Liu; W Martin
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

5.  Manometric disorders in patients with suspected sphincter of Oddi dysfunction.

Authors:  J Toouli; I C Roberts-Thomson; J Dent; J Lee
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

6.  L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle.

Authors:  A Gibson; S Mirzazadeh; A J Hobbs; P K Moore
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

7.  Action of cholecystokinin-octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans.

Authors:  J Toouli; W J Hogan; J E Geenen; W J Dodds; R C Arndorfer
Journal:  Surgery       Date:  1982-09       Impact factor: 3.982

8.  Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi.

Authors:  J Behar; P Biancani
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

9.  Human fasting and postprandial sphincter of Oddi motility.

Authors:  C S Worthley; R A Baker; J Iannos; G T Saccone; J Toouli
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

10.  Role of nitric oxide in motility and secretion of the feline hepatobiliary tract.

Authors:  A Thune; D S Delbro; B Nilsson; S Friman; J Svanvik
Journal:  Scand J Gastroenterol       Date:  1995-07       Impact factor: 2.423

View more
  10 in total

1.  Biliary Tract Dysmotility.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

2.  Nitroester drug's effects and their antagonistic effects against morphine on human sphincter of Oddi motility.

Authors:  Shuo-Dong Wu; Zhen-Hai Zhang; Dong-Yan Li; Jun-Zhe Jin; Jing Kong; Zhong Tian; Wei Wang; Min-Fei Wang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series.

Authors:  Masatoshi Shoji; Hiroshi Sakuma; Yutaka Yoshimitsu; Tsutomu Maeda; Masuo Nakai; Hiroshi Ueda
Journal:  World J Gastrointest Surg       Date:  2013-06-27

Review 4.  Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A "Scoping" Literature Review.

Authors:  Kemmian D Johnson; Abhilash Perisetti; Benjamin Tharian; Ragesh Thandassery; Priya Jamidar; Hemant Goyal; Sumant Inamdar
Journal:  Dig Dis Sci       Date:  2019-12-02       Impact factor: 3.199

5.  Does topical GTN on the sphincter of Oddi facilitate ERCP? A double-blind randomized control trial.

Authors:  A Talwar; C Dare; J Pain
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

6.  A synthetic prostaglandin E1 analog, alprostadil alfadex, relaxes sphincter of Oddi in humans.

Authors:  Tatsuya Koshitani; Tadashi Kodama; Hideki Sato; Junpei Takaaki; Yoichi Imamura; Keimei Kato; Naoki Wakabayashi; Kazuhiko Tokita; Shoji Mitsufuji
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

Review 7.  Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Hemant Pande; Paul Thuluvath
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  The sphincter of oddi.

Authors:  Antonio Bosch; Luis R Peña
Journal:  Dig Dis Sci       Date:  2007-03-14       Impact factor: 3.487

9.  Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.

Authors:  Murat Pekgöz
Journal:  World J Gastroenterol       Date:  2019-08-07       Impact factor: 5.742

10.  Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials.

Authors:  Jiexia Ding; Xi Jin; Yue Pan; Shan Liu; Youming Li
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.